Vident Investment Advisory, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$330,857
-40.6%
58,045
+5.1%
0.01%
-47.6%
Q4 2022$557,210
-22.9%
55,224
+58.0%
0.02%
-12.5%
Q3 2022$723,000
-18.4%
34,950
-2.3%
0.02%
-11.1%
Q2 2022$886,000
+2.8%
35,762
+60.9%
0.03%
+22.7%
Q1 2022$862,000
-20.4%
22,222
+20.1%
0.02%
-21.4%
Q4 2021$1,083,000
+10.8%
18,506
+12.3%
0.03%
-6.7%
Q3 2021$977,000
-36.3%
16,483
-6.7%
0.03%
-36.2%
Q2 2021$1,533,000
+10.5%
17,661
+5.0%
0.05%0.0%
Q1 2021$1,387,000
-9.7%
16,820
-0.4%
0.05%
-25.4%
Q4 2020$1,536,000
-7.8%
16,889
-59.5%
0.06%
-24.1%
Q3 2020$1,666,000
+8.9%
41,670
-6.5%
0.08%
+3.8%
Q2 2020$1,530,000
-10.4%
44,580
-42.0%
0.08%
-28.6%
Q1 2020$1,708,000
+6.8%
76,894
-5.9%
0.11%
+13.1%
Q4 2019$1,599,000
+28.0%
81,695
+1.6%
0.10%
-9.2%
Q3 2019$1,249,000
-25.6%
80,421
-2.8%
0.11%
-19.3%
Q2 2019$1,679,000
-0.8%
82,719
-14.1%
0.14%
+48.4%
Q1 2019$1,692,000
+32.2%
96,315
-3.5%
0.09%
+26.4%
Q4 2018$1,280,000
-59.6%
99,794
-48.7%
0.07%
-41.9%
Q3 2018$3,172,000
+34.7%
194,700
-6.2%
0.12%
+33.3%
Q2 2018$2,355,000207,6760.09%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders